Safer J D, Cohen R N, Hollenberg A N, Wondisford F E
Thyroid Unit, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts 02215, USA.
J Biol Chem. 1998 Nov 13;273(46):30175-82. doi: 10.1074/jbc.273.46.30175.
On positive thyroid hormone response elements (pTREs), thyroid hormone receptor (TR) binding to DNA in the absence of ligand (thyroid hormone, T3) decreases transcription (silencing). Silencing is due to a family of recently described nuclear corepressor proteins (NCoR and SMRT) which bind to the CoR box in the hinge region of TR. Ligand-dependent activation of TR is associated with displacement of corepressors and recruitment of coactivating proteins. Resistance to thyroid hormone (RTH) is due to mutations in the beta isoform of the thyroid hormone receptor (TR-beta). To date, three RTH mutations reportedly with near-normal T3 binding (A234T, R243Q, and R243W) have been described in or near the CoR box. To determine the mechanism of RTH caused by these mutants, the interaction of wild type (wt) and mutant TRs with the corepressor, NCoR, and the coactivator, SRC-1, was tested in gel-shift assays. As expected, NCoR bound wt TR in the absence of T3 and dissociated from TR with increasing T3 concentration. SRC-1 failed to bind wt TR in the absence of T3, but bound to TR with increasing avidity as T3 concentrations rose. At no T3 concentration did both NCoR and SRC-1 bind to wt TR, indicating that their binding to TR was mutually exclusive. Hinge mutants bound NCoR normally in the absence of T3; however, dissociation of NCoR and recruitment of SRC-1 was markedly impaired except at very high T3 concentrations. Importantly, hinge mutant TRs when complexed to DNA bound T3 poorly despite their near-normal T3 binding in solution. These binding studies correlated with functional assays showing defective transactivation of pTREs by hinge mutants except at high T3 concentrations. Thus, we describe a novel mechanism of RTH whereby TR hinge mutants selectively affect T3 binding when complexed to DNA, and prevent NCoR dissociation from TR. Our data also suggest that solution T3 binding by RTH mutants may not accurately reflect physiologically relevant T3 binding by TR when bound to DNA.
在正向甲状腺激素反应元件(pTREs)上,甲状腺激素受体(TR)在没有配体(甲状腺激素,T3)的情况下与DNA结合会降低转录(沉默)。沉默是由于最近描述的一类核共抑制蛋白(NCoR和SMRT),它们与TR铰链区的CoR盒结合。TR的配体依赖性激活与共抑制因子的置换和共激活蛋白的募集有关。甲状腺激素抵抗(RTH)是由于甲状腺激素受体β亚型(TR-β)的突变所致。迄今为止,据报道在CoR盒内或附近已发现三种T3结合近乎正常的RTH突变(A234T、R243Q和R243W)。为了确定这些突变体导致RTH的机制,在凝胶迁移试验中测试了野生型(wt)和突变型TR与共抑制因子NCoR以及共激活因子SRC-1的相互作用。正如预期的那样,NCoR在没有T3的情况下与wt TR结合,并随着T3浓度的增加而从TR上解离。在没有T3的情况下,SRC-1未能与wt TR结合,但随着T3浓度的升高,其与TR的结合亲和力增加。在任何T3浓度下,NCoR和SRC-1都不会同时与wt TR结合,这表明它们与TR的结合是相互排斥的。铰链区突变体在没有T3的情况下正常结合NCoR;然而,除了在非常高的T3浓度下,NCoR的解离和SRC-1的募集明显受损。重要的是,铰链区突变型TR与DNA结合时,尽管它们在溶液中的T3结合近乎正常,但与T3的结合能力很差。这些结合研究与功能分析相关,功能分析表明,除了在高T3浓度下,铰链区突变体对pTREs的反式激活存在缺陷。因此,我们描述了一种RTH的新机制,即TR铰链区突变体在与DNA结合时选择性地影响T3结合,并阻止NCoR从TR上解离。我们的数据还表明,RTH突变体在溶液中的T3结合可能无法准确反映TR与DNA结合时生理相关的T3结合情况。